On June 12th, NACDS submitted a letter to the Department of Human Services Division of Medical Services in support of a proposed rule that would expand the availability of Opioid Use Disorder (OUD) medications and services in the Medicaid program. If adopted, the rule would remove prior authorization for preferred oral drugs for OUD, helping to alleviate administrative burdens on pharmacists and enabling patients to receive their prescriptions in a timelier manner. Additionally, it would allow medication assisted therapy drugs to be exempt from the monthly prescription benefit limit and copay requirement, which would improve access to these important OUD therapies.
For more information, contact NACDS’ Mary Staples at 817-442-1155.